Abstract
The US market for contrast agents and radiopharmaceuticals was valued at over
$3.5 billion in 2007.
This market is comprised of five different markets-radiopharmaceuticals,
computed tomography (CT) and X-ray contrast agents, magnetic resonance imaging
(MRI) contrast agents, ultrasound contrast agents, and power injectors.
View Cart
